Research Shows That Ketamine Delivers Quickly For Treatment-Resistant Depression

In the biggest clinical trial to date testing this drug, the anesthetic ketamine delivered big and quickly to patients with treatment-resistant depression.

Researchers from the Icahn School of Medicine at Mount Sinai carried out the study, testing the drug in patients with major depressive disorder. They found that not only was it effective, but it delivered results in one day – significantly shorter than conventional antidepressants, which often require more than a week to begin to work.

Investigators evaluated 72 people diagnosed with treatment-resistant depression (defined as depression that persists after at least two drug interventions). These patients were split into a treatment arm, which was administered a single IV infusion of ketamine for 40 minutes, and a placebo arm, which received midazolam, an anesthetic also but in a different class.

Ketamine appears to be a safe and effective treatment option

Interviews with patients began after 24 hours, and patients were re-interviewed after seven days. At the first interview, the response rate in the treatment arm was 63.8 percent, compared to 28 percent in the placebo arm.

A week later, the response rate to the ketamine arm was still higher, at 45.7 percent, compared to 18.2 percent in the placebo arm.

Lead author James Murrough, MD, assistant professor of psychiatry at Mount Sinai, said that using midazolam as an active placebo allowed us to independently assess the antidepressant benefit of ketamine, excluding any anesthetic effects. Ketamine continues to show significant promise as a new treatment option for patients with severe and refractory forms of depression.

Dr. Murrough added, "We found that ketamine was safe and well-tolerated and that patients who demonstrated a rapid antidepressant effect after starting ketamine were able to maintain the response throughout the course of the study."

While the results are promising, Murrough said that future studies will need to be larger and placebo-controlled in order to support these findings and determine both the safety and efficacy profile of ketamine as a treatment for depression.

The research was presented at the American Psychiatric Association meeting in San Francisco. The findings should be considered preliminary until published in a peer-reviewed journal.

Source: MNT
Photo: Px Here

Anxiety Support Groups

Latest Post by JustJules Wed, 10/16/2019 - 1:01pm
Comments: 0
Latest Post by MillieM Wed, 10/16/2019 - 11:13am
Comments: 0
Latest Post by MillieM Wed, 10/16/2019 - 11:17am
Comments: 3
Latest Post by MillieM Wed, 10/16/2019 - 11:31am
Comments: 2

More Articles

Postpartum depression and anxiety are real, debilitating disorders that affect some women after they give birth.

Brought on by hormone...

The terms anxiety and stress are often used interchangeably, and it is true that they are related conditions with many of the same symptoms....

This is a topic I have wanted to touch on for a long time. There are so many people that deal with this fear on a day to day basis. Unable to...

People with an excess of MeCP2 protein experience anxiety and a range of other behavioral issues, but Baylor College of Medicine scientists have...

Everyone who lives with bothersome anxiety symptoms should have a pouch or pocket in their bag or backpack that is an emergency calm-kit.

...

More Articles

Like all benzodiazepines, Ativan (generic: lorazepam) can cause both physical and psychological dependence. Stopping it suddenly often results in...

By quieting the mind, we can reduce those thoughts that cause agitation and self-doubt and distract us from the present moment.

A centuries...

The antidepressant Nardil, in the class of antidepressants known as monoamine oxidase inhibitors (MAOIs), is also frequently prescribed as a...

There are a lot of techniques and good advice available on how to overcome panic disorder, from watching what you eat and drink to changing the...

A study published in the journal Archives of Psychiatry has found that anxiety and mood disorders are more common in people with low incomes....

Anxiety attacks are very frightening experiences, and for chronic sufferers, they can seriously impact everyday life. While there are things you...

If you've found that being under stress has an effect on your appetite and weight, you're in good company. While some people lose weight when they...

Beta-blockers are a class of drugs most commonly used to treat heart conditions, although they are useful in the treatment of a variety of other...

Anxiety disorders are complex, influenced by a number of chemical, behavioral, and situational factors. There are several neurotransmitters in the...

If you suffer from an anxiety disorder, you may occasionally experience an anxiety attack.

An anxiety attack is described as a sudden...

Lexapro is an SSRI antidepressant that is FDA approved for the treatment of generalized anxiety disorder (GAD). It is one of the antidepressants...

While one might assume that children with extreme social anxiety are hyper-aware of other people's emotions, it turns out that the opposite is...

Around 40 million American adults suffer from some kind of anxiety disorder. While there are effective therapies and medications that make it...

Anxiety sufferers in the 21st century have a relatively new avenue of help and support: the Internet. As more and more people turn to Google first...

An article from Prevention provides a list of 6 strange physical symptoms of stress that you may not even associate with too much stress in your...